Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ARYA Sciences Acquisition Corp II | 499,000 | reported | 09 Jun 2020 | tx 1+499,000 |
| ARYA Sciences Acquisition Corp V | 499,000 | reported | 15 Jul 2021 | tx 1+499,000 |
| Perceptive Capital Solutions Corp | 286,250 | reported | 13 Jun 2024 | tx 1+286,250 |
| Nautilus Biotechnology, Inc. | 45,000 | reported | 14 Jun 2024 | tx 9+4,866,402−4,146,500 |
| Lyra Therapeutics, Inc. | 30,000 | reported | 13 Jun 2024 | tx 5+79,000 |
| ARYA Sciences Acquisition Corp IV | 0 | reported | 31 Jul 2024 | tx 4+499,000−4,146,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Jul 2024 | OTHER | ARYA Sciences Acquisition Corp IV | 499,000 | — | |
| 31 Jul 2024 | OTHER | ARYA Sciences Acquisition Corp IV | 1,000,000 | — | deriv |
| 31 Jul 2024 | OTHER | ARYA Sciences Acquisition Corp IV | 2,647,500 | — | deriv |
| 14 Jun 2024 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 45,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Lyra Therapeutics, Inc. | 30,000 | 0.00 USD | deriv |
| 13 Jun 2024 | GRANT_AWARD | Perceptive Capital Solutions Corp | 286,250 | 10.00 USD | |
| 30 Jun 2023 | GRANT_AWARD | Lyra Therapeutics, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Jun 2023 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 45,000 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | Lyra Therapeutics, Inc. | 7,250 | 0.00 USD | deriv |
| 15 Jun 2022 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 86,467 | 0.00 USD | deriv |
| 15 Jul 2021 | GRANT_AWARD | ARYA Sciences Acquisition Corp V | 499,000 | 10.00 USD | |
| 09 Jun 2021 | CONVERSION | Nautilus Biotechnology, Inc. | 499,000 | — | |
| 09 Jun 2021 | CONVERSION | Nautilus Biotechnology, Inc. | 3,647,500 | — | |
| 09 Jun 2021 | CONVERSION | Nautilus Biotechnology, Inc. | 499,000 | — | |
| 09 Jun 2021 | GRANT_AWARD | Nautilus Biotechnology, Inc. | 44,435 | 0.00 USD | deriv |
| 09 Jun 2021 | CONVERSION | Nautilus Biotechnology, Inc. | 3,647,500 | — | deriv |
| 26 May 2021 | GRANT_AWARD | Lyra Therapeutics, Inc. | 7,250 | 0.00 USD | deriv |
| 02 Mar 2021 | GRANT_AWARD | ARYA Sciences Acquisition Corp IV | 499,000 | 10.00 USD | |
| 11 Aug 2020 | OTHER | Nautilus Biotechnology, Inc. | 499,000 | 10.00 USD | |
| 09 Jun 2020 | OTHER | ARYA Sciences Acquisition Corp II | 499,000 | 10.00 USD | |
| 30 Apr 2020 | GRANT_AWARD | Lyra Therapeutics, Inc. | 14,500 | 0.00 USD | deriv |